购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Others
    (4)
TargetMol | Tags 通过 货期 筛选
  • 6-8周
    (1)
  • 8-10周
    (3)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "ym 543, ym-543, ym543"的结果
筛选
搜索结果
TargetMol产品目录中 "

ym 543, ym-543, ym543

"的结果
  • 抑制剂&激动剂
    4
    TargetMol | Inhibitors_Agonists
  • YM543 free base
    T68922655237-16-4
    YM543 free base 为口服有效的钠-葡萄糖协同转运蛋白(SGLT) 2抑制剂,主要用于降低血糖水平,适用于糖尿病研究。
    • ¥ 12800
    8-10周
    规格
    数量
  • BMS986126
    T703891610017-20-3
    BMS-986122 is a IRAK4 Inhibitor. BMS-986126 attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity. BMS-986126 inhibited TLR7- and TLR9-dependent responses using cells derived from lupus patients, suggesting that inhibition of IRAK4 has the potential for therapeutic benefit in treating lupus.
    • ¥ 15000
    8-10周
    规格
    数量
  • YM-543 trimethylamine
    ASP 543,ASP-543,ASP543
    T29188918802-70-7
    YM-543, a sodium-glucose transporter 2 (SGLT-2) inhibitor, is used potentially for the treatment of type 2 diabetes.
    • ¥ 10600
    6-8周
    规格
    数量
  • YM-543 choline
    T703901610007-47-0
    YM-543, also known as ASP-543, is a selective SGLT2 inhibitor. Sodium-glucose cotransporter 2 (SGLT2) is a specifically expressed transporter in the kidney that plays an important role in renal glucose reabsorption, and its inhibition may present a novel therapeutic strategy for treating diabetes. YM543 potently and selectively inhibited mouse and human SGLT2 activities at nanomolar ranges. In vivo single oral administration of YM543 dose-dependently and significantly reduced blood glucose levels and improved glucose tolerance with a concomitant increase in urinary glucose excretion in KK Ay type 2 diabetic mice, effects that were sustained even after 12 h.
    • ¥ 12800
    8-10周
    规格
    数量